Found 136 matching trials
Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART PHASE1 Background:
Despite the introduction of highly effective antiretroviral th...
Show More Location
Oslo University Hospital, Ullevål
Learn More & Join Trial
HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer PHASE1 RATIONALE: Vaccines made from the HER2/neu antigen may make the body build ...
Show More Location
University of Washington School of Medicine
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer PHASE1 RATIONALE: Vaccines made from peptides may make the body build an immune re...
Show More Location
University of Virginia Cancer Center
Learn More & Join Trial
IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable Disease PHASE2 This study was conducted in order to evaluate the efficacy and safety of th...
Show More Location
Medizinische Universität Salzburg - Universitätsklinik für Innere Medizin III
Learn More & Join Trial
Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer PHASE2 The purpose of this study is to evaluate the safety and feasibility of long...
Show More Status
Active Not Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Learn More & Join Trial
Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery PHASE2 RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluation of the Effects of Local Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Adjuvant Administration on Dendritic Cells in Skin of Melanoma Patients and in Sentinel Lymph Nodes: MEL38 NA Goal: To characterize the cellular events that occur in vivo after vaccinat...
Show More Location
University of Virginia
Learn More & Join Trial
Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP PHASE1 The effectiveness of a vaccine can be improved by using a "prime boost stra...
Show More Location
Alabama Vaccine CRS
Learn More & Join Trial
SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE) PHASE2 The main purpose of this study is to determine whether adding SurVaxM to st...
Show More Location
University of California
Learn More & Join Trial
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission PHASE3 RATIONALE: Vaccines made from a peptide may help the body build an effectiv...
Show More Location
Mayo Clinic Scottsdale
Learn More & Join Trial